BriaCell Therapeutics Corp Warrant
BCTXZ
3 hedge funds and large institutions have $311K invested in BriaCell Therapeutics Corp Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
9.99% less ownership
Funds ownership: 49.42% → 39.44% (-10%)
74% less capital invested
Capital invested by funds: $1.21M → $311K (-$899K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$74.3K |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
-$2.45K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$372 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Heights Capital Management
San Francisco,
California
| $186K | -$2.45K | -7,383 | -1% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $125K | -$74.3K | -224,255 | -37% |
|
|
3
UBS Group
Zurich,
Switzerland
| $22 | -$372 | -1,123 | -94% |
|
BCTXZ Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXZ) for Q3 2025, worth a combined $311K — down 74% from $1.21M a quarter earlier.
Fund positioning in BCTXZ was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Sabby Management, cutting an estimated $74.3K.
- 3 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXZ) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $311K of BriaCell Therapeutics Corp Warrant stock for Q3 2025, down 74% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q3 2025 and 0 closed out.
- The largest BriaCell Therapeutics Corp Warrant seller in Q3 2025 was Sabby Management, an estimated $74.3K sold.
Based on aggregated 13F filings for Q3 2025.